Foralumab is an antibody being developed by Tiziana Life Sciences that's designed to block CD3, a protein on the surface of ...

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly‘s antibody therapy donanemab, now Kisunla, for certain ...

What is Kisunla for Alzheimer’s? Kisunla (donanemab-azbt) is an antibody-based therapy approved in the U.S. to treat adults with early symptomatic Alzheimer’s disease. This includes people with mild ...

The U.S. Food and Drug Administration (FDA) has agreed to review a supplemental application seeking authorization of once-monthly maintenance dosing for Leqembi (lecanemab), an approved treatment for ...

An advisory committee to the U.S. Food and Drug Administration (FDA) has unanimously voted in favor of donanemab, an anti-amyloid therapy developed by Eli Lilly that’s currently up for approval as a ...

Providing care and support for someone with a chronic health challenge comes with its own unique set of stresses. You may be juggling doctors’ appointments, timing multiple medications, and keeping on ...

We’re barely into the summer months, and temperatures across the United States are soaring. Heat is expected to intensify as we get deeper into the season, with U.S. temperatures surpassing those of ...

The safety and effectiveness of oral therapy candidate buntanetap are comparable in people with early Alzheimer’s disease regardless of whether they do or do not carry a genetic risk factor known as ...

Note: This story was updated June 21, 2024, to correct that SNK01 was given approval by NKGen Biotech’s Safety Review Committee. SNK01, a natural killer (NK) cell therapy being developed by NKGen ...